[1]Matsukawa S, Morita K, Negishi A, et al.Galectin-7 as a potential predictive marker of chemo- and/or radio-therapy resistance in oral squamous cell carcinoma[J].Cancer Med, 2014, 3(2):349-361[2]Anonym.Cancer Stat Facts: Oral Cavity and Pharynx Cancer[EB/OL]. https://seer.cancer.gov/statfacts/html/oralcav.html. 2017-01-12[3]Funk GF, Karnell LH, Robinson RA, et al.Presentation, treatment, and outcome of oral cavity cancer: a National Cancer Data Base report[J].Head Neck, 2002, 24(2):165-180[4]Takahashi H, Yanamoto S, Yamada S, et al.Effects of postoperative chemotherapy and radiotherapy on patients with squamous cell carcinoma of the oral cavity and multiple regional lymph node metastases[J].Int J Ora Maxillofac Surg, 2014, 43(6):680-685[5]Gupta S, Gupta S.Role of human papillomavirus in oral squamous cell carcinoma and oral potentially malignant disorders: A review of the literature[J].Indian J Dent, 2015, 6(2):91-98[6]陈速.液基细胞学检查技术在临床肿瘤筛查的研究进展[J].世界科技研究与发展, 2008, 30(4):489-490[7]赵宇阳, 李春辉.TCT制片和手工滴片方法在非妇科脱落细胞学诊断中的应用[J].诊断病理学杂志, 2013, 20(7):439-440[8]曹晓哲, 周宾, 曹志星, 等.非妇科领域应用液基细胞学与传统涂片细胞核定量参数的比较研究[J].中国体视学与图像分析, 2012, 17(1):65-69[9]王居祥, 胡跃清.常用肿瘤标志物临床手册[M]. 东南大学出版社, 2016.[10]陈彦平, 杨凯成,梁玉林,等.PPARγ和PCNA在口腔鳞癌组织的表达及临床意义[J].第三军医大学学报, 2011, 33(16):1718-1721[11]Karthikeyan S, Manoharan S.Cromolyn inhibits 7,12-dimethylbenz (a) anthracene induced oral cancer through apoptotic induction and suppression of cell proliferation[J].Int J Pharma Bio Sci, 2016, 7(1):35-42[12]陆晓旻, 彭春.宫颈脱落细胞PCNA检测在宫颈癌诊断中的应用价值[J].肿瘤基础与临床, 2009, 22(1):71-72[13]Gissi DB, Gabusi A, Servidio D, et al.Predictive Role of p53 Protein as a Single Marker or Associated with ki67 Antigen in Oral Leukoplakia: A Retrospective Longitudinal Study[J].Open Dent J, 2015, 9:41-45[14]Gouvêa AF, Vargas PA, Coletta RD, et al.Clinicopathological features and immunohistochemical of p53, Ki-67, Mcm-2 and Mcm-5 in proliferative verrucous leukoplakia[J].J Oral Pathol Med, 2010, 39(6):447-452[15]何伟, 肖严, 陈卫民.口腔鳞癌组织中Ki-67和p53蛋白的表达[J].上海口腔医学, 2015, 24(2):228-231[16]王娇, 舒丽莎, 陈书玲, 等.P16、Ki67联合细胞学检查在宫颈脱落细胞中的诊断意义[J].中国妇幼保健, 2016, 31(10):2176-2179[17]Jafri MA, Ansari SA, Alqahtani MH, et al.Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies[J].Genome Med, 2016, 8(1):69-[18]Hirano Y, Fujita K, Suzuki K, et al.Telomerase activity as an indicator of potentially malignant adrenal tumors[J].Cancer, 2015, 83(4):772-776[19]Raghunandan BN, Sanjai K, Kumaraswamy J, et al.Expression of human telomerase reverse transcriptase protein in oral epithelial dysplasia and oral squamous cell carcinoma: An immunohistochemical study[J].J Oral Maxillofac Pathol, 2016, 20(1):96-101[20]Huang J, Lyu H, Wang J, et al.MicroRNA regulation and therapeutic targeting of survivin in cancer[J].Am J Cancer Res, 2015, 5(1):20-31[21]Mishra R, Palve V, Kannan S, et al.High of survivin and its splice variants survivin ΔEx3 and survivin 2 B in oral cancers[J].Oral Surg Oral Med Oral Pathol Oral Radiol, 2015, 120(4):497-507[22]陈启林, 胡孝丽, 徐琼莉, 等.IL-17、COX-2在口腔扁平苔藓和口腔鳞癌中的表达分析[J].现代中西医结合杂志, 2014, 23(30):3310-3312[23]Amirchaghmaghi M, Mohtasham N, Mozaffari PM.Comparison of COX2 between oral squamous cell carcinoma, leukoplakia and normal mucosa[J].J Contemp Dent Pract, 2012, 13(2):205-209[24]Francis G, Dileep Kumar U, Nalinakumari KR, et al.Accumulation of inactive p53 protein in oral squamous cell carcinoma: stabilization by protein interaction[J].Euro J Oral Sci, 2013, 121(1):21-28[25]Leyva-Huerta ER, Ledesma-Montes C, Rojo-Botello RE, et al.P53 and bcl-2 immuno in patients with oral lichen planus and oral squamous cell carcinoma[J].Med Oral Patol Oral Cir Bucal, 2012, 17(5):e745-e750[26]Kimmelman A C.Metabolic Dependencies in RAS-Driven Cancers[J].Clin Cancer Res, 2015, 21(8):1828-1834[27]Drosten M, Lechuga CG, Barbacid M.Genetic analysis of Ras genes in epidermal development and tumorigenesis[J].Small Gtpases, 2013, 4(4):236-241[28]王莉红, 张弘彬, 刘婷姣, 等.H-ras和pERK1/2蛋白在舌鳞癌中的表达及相互关系[J].中国医科大学学报, 2006, 35(4):397-398[29]van der Weyden L, Alcolea MP, Jones PH, et al.Acute sensitivity of the oral mucosa to oncogenic K-ras[J].J Pathol, 2011, 224(1):22-32[30]Murugan AK, Munirajan AK, Tsuchida N.Ras oncogenes in oral cancer: the past 20 years[J].Oral Oncol, 2012, 48(5):383-392[31]张健, 郇小凤, 张平, 等.口腔鳞状细胞癌中CK19表达及其临床意义的Meta分析[J].中国循证医学杂志, 2015, 15(10):1142-1147[32]Babiker AY, Rahmani AH, Abdalaziz MS, et al.Expressional analysis of p16 and cytokeratin19 protein in the genesis of oral squamous cell carcinoma patients[J].Int J Clin Exp Med, 2014, 7(6):1524-1530[33]刘树范, 阚秀.细胞病理学[M]. 中国协和医科大学出版社, 2011. |